By Sara Heath March 29, 2023 – The patient portal might be too clunky or onerous to be useful in closing care gaps, with new research finding that patient portal messages didn’t do much to…
Continue Reading
In todays fast-paced world, it is easy to miss out on important information, especially if you are trying to keep up with a lot of different sources. That is where the daily digest comes in – it is a tool that compiles all the posts created on the previous day, providing you with a convenient summary of everything that happened so you can stay informed, educated, and engaged with the Digital Health world around you.
Continue Reading
MedicalDirector UK’s Helix VaxApp has received approval from NHS England to be used across the health service’s Covid and flu vaccination programmes. This milestone marks a significant achievement in the ongoing efforts to combat Covid-19…
Continue Reading
Lucira Health announced it had filed for Chapter 11 bankruptcy last week just as the diagnostics company received Emergency Use Authorization from the FDA for an at-home combination COVID-19 and flu test. In the company’s…
Continue Reading
Cough, fever, and breathing difficulty could signal a Covid-19 infection. It could also be the flu. A Lucira Health diagnostic is now the first one authorized by the FDA to identify the culprit virus…
Continue Reading
‘Tripledemic’ concerns have been on the rise with the collision of flu, Covid-19, and respiratory syncytial virus (RSV) wreaking havoc in clinics and hospitals. Yet staff are expected to provide smooth, fast, and effective care journeys for all, no matter the volume of patients. We know, however, that everything doesn’t always go as planned when patient traffic explodes. Bottlenecks like long wait times and limited appointment options inevitably skyrocket, and staff bear the brunt of patients who (understandably) want to be seen immediately, in conjunction with staff members intermittently being out sick themselves.
Living in an environment of extreme health unpredictability affects…
A Moderna messenger RNA vaccine for influenza now has preliminary data from a pivotal study showing the shot prompted a strong immune response to the more common strains of the virus but fell short against less common strains.
The results reported Thursday are from one of two pivotal studies for the Moderna vaccine, mRNA-1010, which is assessing the shot for safety and immune response. A separate Phase 3 study is evaluating the shot for efficacy. Results from that study could come as early as next month. Moderna’s vaccine encodes hemagglutinin, a protein on the surface of the influenza virus that is also…
![How to Leverage Diagnostic Development to Guard Against RSV, Flu and Covid-19 [Sponsored]](https://i0.wp.com/www.mediformatica.com/wp-content/uploads/2023/02/how-to-leverage-diagnostic-development-to-guard-against-rsv-flu-and-covid-19-sponsored.jpg?fit=600%2C349&ssl=1)
For the first two years of the Covid-19 pandemic, healthcare professionals focused on understanding the Covid-19 virus, how best to guard against it, and developing tests to detect it. They also tracked, aggregated, and analyzed health data to assess and monitor the public health threat on a regional, state and country-wide level. In the longer term, vaccine development and distribution were used to slow the spread to avoid a collapse of the health system and to reduce the potency of the virus for the majority of people.
More recently, attention has shifted to the long perceived threat of viruses coming together with…
